News | March 04, 2022
USFDA refuses to grant EUA to Covaxin for padeatric use
Covaxin is not approved in the USA for any age group
Covaxin is not approved in the USA for any age group
The product will be manufactured at Lupin’s facility in Pithampur, India
USFDA's industry recommendations and cancer Moonshot aim to improve lives of patients and their families
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
If approved, Opdivo plus chemotherapy would be the first neoadjuvant immunotherapy-based option for patients with resectable non-small cell lung cancer in the U.S.
Vonjo is the first approved therapy to specifically address the needs of adult cytopenic myelofibrosis patients
Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad
New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure
Subscribe To Our Newsletter & Stay Updated
